Literature DB >> 19117936

Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables.

Johanna M Seddon1, Robyn Reynolds, Julian Maller, Jesen A Fagerness, Mark J Daly, Bernard Rosner.   

Abstract

PURPOSE: The joint effects of genetic, ocular, and environmental variables were evaluated and predictive models for prevalence and incidence of AMD were assessed.
METHODS: Participants in the multicenter Age-Related Eye Disease Study (AREDS) were included in a prospective evaluation of 1446 individuals, of which 279 progressed to advanced AMD (geographic atrophy or neovascular disease) and 1167 did not progress during 6.3 years of follow-up. For prevalent AMD, 509 advanced cases were compared with 222 controls. Covariates for the incidence analysis included age, sex, education, smoking, body mass index (BMI), baseline AMD grade, and the AREDS vitamin-mineral treatment assignment. DNA specimens were evaluated for six variants in five genes related to AMD. Unconditional logistic regression analyses were performed for prevalent and incident advanced AMD. An algorithm was developed and receiver operating characteristic curves and C statistics were calculated to assess the predictive ability of risk scores to discriminate progressors from nonprogressors.
RESULTS: All genetic polymorphisms were independently related to prevalence of advanced AMD, controlling for genetic factors, smoking, BMI, and AREDS treatment. Multivariate odds ratios (ORs) were 3.5 (95% confidence interval [CI], 1.7-7.1) for CFH Y402H; 3.7 (95% CI, 1.6-8.4) for CFH rs1410996; 25.4 (95% CI, 8.6-75.1) for LOC387715 A69S (ARMS2); 0.3 (95% CI, 0.1-0.7) for C2 E318D; 0.3 (95% CI, 0.1-0.5) for CFB; and 3.6 (95% CI, 1.4-9.4) for C3 R102G, comparing the homozygous risk/protective genotypes to the referent genotypes. For incident AMD, all these variants except CFB were significantly related to progression to advanced AMD, after controlling for baseline AMD grade and other factors, with ORs from 1.8 to 4.0 for presence of two risk alleles and 0.4 for the protective allele. An interaction was seen between CFH402H and treatment, after controlling for all genotypes. Smoking was independently related to AMD, with a multiplicative joint effect with genotype on AMD risk. The C statistic for the full model with all variables was 0.831 for progression to advanced AMD.
CONCLUSIONS: Factors reflective of nature and nurture are independently related to prevalence and incidence of advanced AMD, with excellent predictive power.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19117936      PMCID: PMC3772781          DOI: 10.1167/iovs.08-3064

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  36 in total

1.  Complement factor H polymorphism in age-related macular degeneration.

Authors:  Robert J Klein; Caroline Zeiss; Emily Y Chew; Jen-Yue Tsai; Richard S Sackler; Chad Haynes; Alice K Henning; John Paul SanGiovanni; Shrikant M Mane; Susan T Mayne; Michael B Bracken; Frederick L Ferris; Jurg Ott; Colin Barnstable; Josephine Hoh
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

2.  Susceptibility genes for age-related maculopathy on chromosome 10q26.

Authors:  Johanna Jakobsdottir; Yvette P Conley; Daniel E Weeks; Tammy S Mah; Robert E Ferrell; Michael B Gorin
Journal:  Am J Hum Genet       Date:  2005-07-26       Impact factor: 11.025

Review 3.  The genetics of age-related macular degeneration: a review of progress to date.

Authors:  Stephen Haddad; Clara A Chen; Susan L Santangelo; Johanna M Seddon
Journal:  Surv Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 6.048

4.  Complement factor H polymorphism and age-related macular degeneration.

Authors:  Albert O Edwards; Robert Ritter; Kenneth J Abel; Alisa Manning; Carolien Panhuysen; Lindsay A Farrer
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

5.  Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19.

Authors:  Traci E Clemons; Roy C Milton; Ronald Klein; Johanna M Seddon; Frederick L Ferris
Journal:  Ophthalmology       Date:  2005-04       Impact factor: 12.079

6.  Evaluation of the clinical age-related maculopathy staging system.

Authors:  Johanna M Seddon; Sanjay Sharma; Ron A Adelman
Journal:  Ophthalmology       Date:  2006-02       Impact factor: 12.079

7.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.

Authors:  Gregory S Hageman; Don H Anderson; Lincoln V Johnson; Lisa S Hancox; Andrew J Taiber; Lisa I Hardisty; Jill L Hageman; Heather A Stockman; James D Borchardt; Karen M Gehrs; Richard J H Smith; Giuliana Silvestri; Stephen R Russell; Caroline C W Klaver; Irene Barbazetto; Stanley Chang; Lawrence A Yannuzzi; Gaetano R Barile; John C Merriam; R Theodore Smith; Adam K Olsh; Julie Bergeron; Jana Zernant; Joanna E Merriam; Bert Gold; Michael Dean; Rando Allikmets
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-03       Impact factor: 11.205

8.  C-reactive protein and homocysteine are associated with dietary and behavioral risk factors for age-related macular degeneration.

Authors:  Johanna M Seddon; Gary Gensler; Michael L Klein; Roy C Milton
Journal:  Nutrition       Date:  2006-04       Impact factor: 4.008

9.  A prospective study of cigarette smoking and age-related macular degeneration in women.

Authors:  J M Seddon; W C Willett; F E Speizer; S E Hankinson
Journal:  JAMA       Date:  1996-10-09       Impact factor: 56.272

10.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.

Authors:  Bert Gold; Joanna E Merriam; Jana Zernant; Lisa S Hancox; Andrew J Taiber; Karen Gehrs; Kevin Cramer; Julia Neel; Julie Bergeron; Gaetano R Barile; R Theodore Smith; Gregory S Hageman; Michael Dean; Rando Allikmets
Journal:  Nat Genet       Date:  2006-03-05       Impact factor: 38.330

View more
  132 in total

1.  Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models.

Authors:  Yi Yu; Robyn Reynolds; Bernard Rosner; Mark J Daly; Johanna M Seddon
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-21       Impact factor: 4.799

2.  Analytical and simulation methods for estimating the potential predictive ability of genetic profiling: a comparison of methods and results.

Authors:  Suman Kundu; Lennart C Karssen; A Cecile J W Janssens
Journal:  Eur J Hum Genet       Date:  2012-05-30       Impact factor: 4.246

Review 3.  Age-related macular degeneration: genetic and environmental factors of disease.

Authors:  Yuhong Chen; Matthew Bedell; Kang Zhang
Journal:  Mol Interv       Date:  2010-10

Review 4.  [Clinical characteristics, progression and risk factors of geographic atrophy].

Authors:  C K Brinkmann; C Adrion; U Mansmann; S Schmitz-Valckenberg; F G Holz
Journal:  Ophthalmologe       Date:  2010-11       Impact factor: 1.059

5.  Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors.

Authors:  Johanna M Seddon; Robyn Reynolds; Yi Yu; Mark J Daly; Bernard Rosner
Journal:  Ophthalmology       Date:  2011-09-29       Impact factor: 12.079

Review 6.  Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.

Authors:  Goldis Malek; Eleonora M Lad
Journal:  Cell Mol Life Sci       Date:  2014-08-26       Impact factor: 9.261

7.  Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells.

Authors:  Tim U Krohne; Peter D Westenskow; Toshihide Kurihara; David F Friedlander; Mandy Lehmann; Alison L Dorsey; Wenlin Li; Saiyong Zhu; Andrew Schultz; Junhua Wang; Gary Siuzdak; Sheng Ding; Martin Friedlander
Journal:  Stem Cells Transl Med       Date:  2012-02       Impact factor: 6.940

Review 8.  Genetic and environmental underpinnings to age-related ocular diseases.

Authors:  Johanna M Seddon
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-13       Impact factor: 4.799

9.  Misclassification can explain most apparent regression of age-related macular degeneration: results from multistate models with misclassification.

Authors:  Ronald E Gangnon; Kristine E Lee; Barbara E K Klein; Sudha K Iyengar; Theru A Sivakumaran; Ronald Klein
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

10.  Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Chelsea E Myers; Stacy M Meuer; Ronald E Gangnon; Theru A Sivakumaran; Sudha K Iyengar; Kristine E Lee; Barbara E K Klein
Journal:  JAMA Ophthalmol       Date:  2013-03       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.